Rate My Professor Lianne Parkin

Professor Parkin's research centers on epidemiology and pharmacoepidemiology, leveraging routinely collected electronic health and pharmaceutical dispensing data to investigate the utilization and safety of medicines and medical devices, with a particular emphasis on medicines use during pregnancy and venous thromboembolism. Her contributions include studies on smoking cessation pharmacotherapies, opioid use, and congenital malformations in pregnancy. Key publications are Robijn et al. (2025), 'Effectiveness of smoking cessation pharmacotherapies during pregnancy: A multi-national population-based study' in Addiction; Tran et al. (2025), 'Risk of major congenital malformations following prenatal exposure to smoking cessation medicines' in JAMA Internal Medicine; Brett et al. (2025), 'Global trends in analgesic opioid use in pregnancy: A retrospective cohort study' in Anesthesiology; and Robijn et al. (2024), 'Smoking cessation pharmacotherapy use in pregnancy' in JAMA Network Open. Additional works address metformin adherence in type 2 diabetes, antidepressant dispensing around pregnancy, and insulin pump utilization disparities. She delivered her Inaugural Professorial Lecture on 14 September 2023.